The Latest Breaking News from Nasdaq

Lululemon Athletica's (NASDAQ:LULU) short percent of float has risen 26.13% since its last report. The company recently reported that it has 2.80 million shares sold short, which is 2.51% of all regular shares that are available for trading.

Analysts have provided the following ratings for Northern Trust (NASDAQ:NTRS) within the last quarter:

Monday marks the last chance for investors to receive the next dividend payout from Tractor Supply (NASDAQ:TSCO).

Monday marks the last chance for investors to receive the next dividend payout from Teradyne (NASDAQ:TER).

Monday marks the last chance for investors to receive the next dividend payout from H&E Equipment Servs (NASDAQ:HEES).

Over the past two years, technology companies have enjoyed explosive growth as investors were upbeat about the prospects for the sector at a time when people relied on technology to stay connected while cooped up in their homes.

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) has announced topline safety and efficacy data from its Phase 2 trial of RP-L201 gene therapy in severe Leukocyte Adhesion Deficiency-I (LAD-I). Data were shared at the American Society of Gene and Cell Therapy. LAD-I is a disorder that causes the immune system to malfunction, resulting in immunodeficiency. Immunodeficiencies…

Microsoft Corporation (NASDAQ: MSFT) spiked up about 1% higher on Thursday morning after a bearish day on Wednesday saw the tech giant slide almost 5%. Stocks in the broader technology sector have been hammered over recent weeks, leading the S&P 500 down over 15% since March 29.

Clene Inc. (NASDAQ: CLNN) shares are trading higher by 10.81% at $2.46 after the company received a $3 million loan from the Maryland Board of Public Works to support production for its lead drug candidate CNM-Au8.

Canaan Inc (NASDAQ:CAN) reported first-quarter FY22 revenue growth of 236.7% year-on-year to $213.9 million. Earnings per ADS were $0.41. The Y/Y increase was mainly attributable to the rise in total computing power sold and the average selling price per Thash/s. Total computing power sold increased 119.1% Y/Y to 4.3 million Thash/s. Canaan held…

Tricida Inc (NASDAQ:TCDA) said that, as anticipated, it is stopping its VALOR-CKD renal outcomes trial early for administrative reasons under the existing study protocol to allow for six months of financial runway following topline results, currently anticipated in early Q4 2022.   VALOR-CKD trial, initiated in 2018, was designed to evaluate veverimer's ability to…